Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

483 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    《私募股权投资基金大看台》系列文章之六

    在上一篇《私募股权投资基金大看台》系列文章中,我们对法律尽职调查做了概要性介绍。本文将在其基础上,对医药大健康领域的尽职调查$
    ChinaIntellectual Property
    AnJie Broad Law Firm
    AnJie Broad Law Firm
  • Article

    【华源原创】传统行业的新玩法:初探烟草产品电子化趋势

    比如说手机,突然变得"只剩下一块屏幕"了;还有汽车,众多电动汽车纷纷出现暂且不表,新出厂的燃油车型号,也恨不得中控全都变成屏幕。
    ChinaIntellectual Property
    Kangxin
    Kangxin
  • Article

    进口未批的境外新药不按假药论处,但并非就是无罪

    2019年8月26日,《药品管理法》经修订后通过,其中原法第三十九条第二款的"医疗单位临床急需或者个人自用进口的少量药品,按照国家有关规定
ChinaFood, Drugs, Healthcare, Life Sciences
DeHeng Law Offices
DeHeng Law Offices
  • Article

    中美经贸协议中"专利有效期的延长"部分,释放出哪些信号?

    中美双方于2020年1月15日签署的...
    ChinaIntellectual Property
    Kangxin
    Kangxin
  • Article

    中美经贸协议中"专利有效期的延长"部分,释放出哪些信号?

    中美双方于2020年1月15日签署的《中华人民共和国政府和美利坚合众国政府经济贸易协议》(以下简称《协议》),对于两国乃至世界来说都是一È
    ChinaIntellectual Property
    Kangxin
    Kangxin
  • Article

    China On The Move: Lessons From China's 2024 National Negotiation Of Drug Prices

    China's share of the global drug development pipeline grew from 3% in 2013 to 28% in 2023, positioning China as the second-largest region for clinical trials after the United States.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Greenberg Traurig
    Greenberg Traurig
  • Article

    【华源原创】烟草薄片——HNB烟草制品的潜在进步力量

    随着国际主要烟草公司的业务转型,新型烟草发展方兴未艾。我国新型烟草加工产业链日趋成熟,对加热不燃烧烟草制品的政策监管在国内市
    ChinaFood, Drugs, Healthcare, Life Sciences
    Kangxin
    Kangxin
  • Article

    China Update – Drug Patents

    First pre-trial injunction granted for a drug patent in China: Astellas Pharma v Zhejiang Hisun Pharmaceutical.
    ChinaIntellectual Property
    Toby Mak
    Toby Mak
  • Article

    Key Points Of The New Revision Of The Chinese Patent Law

    On October 17, 2020, the third draft of the 4th revision of the Chinese Patent Law was approved by the Standing Committee of the National People's Congress and will come into force on June 1, 2021.
    ChinaIntellectual Property
    Kangxin
    Kangxin
  • Article

    药品发明专利期限补偿及其间的保护范围

    药品发明专利涉及的药品需经国家药品监督管理局审批后才可上市;由于药品审查周期较长,很可能专利已授权但是上市审批尚未完成。为保障专
    ChinaIntellectual Property
    AFD China
    AFD China
  • Article

    Overview Of China Drug Review Annual Report (2015-2021)

    Since 2013, the National Medical Products Administration ("NMPA") Center for Drug Evaluation ("CDE") has been releasing a Drug Review Annual Report ("Report") each year, which summarizes...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    Safeguards Of Dapagliflozin's Half Billion USD Sales In China: AstraZeneca

    In December 2024, the State Council issued the "Opinions on Comprehensively Deepening the Reform of the Supervision of Drugs and Medical Devices to Promote the High-Quality Development.
    ChinaIntellectual Property
    Rouse
    Rouse
  • Article

    중복 권한 수여에 관한 사례에 대한 간단한 분석

    《특허법》 제9조는 같은 발명...
    ChinaIntellectual Property
    Kangxin
    Kangxin
  • Article

    Measures For Supervision And Administration Of The Quality Of Drug Supply And Use

    To implement the Drug Administration Law of the PRC, a draft version of the Measures for Supervision and Administration of Drug Supply was publicized in September 2019 for public opinion
    ChinaFood, Drugs, Healthcare, Life Sciences
    CMS
    CMS
  • Article

    GossIP – July, 2021, HFG Law&Intellectual Property Newsletter

    Brunello di Montalcino is one of the most well-known and good wines of Italy, and we must say that its fame has gone beyond the borders of Europe and reached Asia, where it's very popular, and is considered to enjoying "good reputation".
    ChinaIntellectual Property
    HFG Law & Intellectual Property
    HFG Law & Intellectual Property
  • Article

    The Antitrust Enforcement Announcement Of SAIC: Chongqing Qingyang Pharma Abused Its Market Dominance By Refusing To Deal (In Chinese)

    经国家工商行政管理总局授权,重庆市工商行政管理局于2014年12月对重庆青阳药业有限公司涉嫌滥用市场支配地位拒绝交易行为进行立案调查...
    ChinaAntitrust/Competition Law
    AnJie Broad Law Firm
    AnJie Broad Law Firm
  • Article

    China On The Move: China's Healthcare And Life Sciences Regulatory Evolution In 2025

    In the first half of 2025, China's healthcare and life sciences regulatory framework underwent a wave of important reforms. These developments reflect the country's continued efforts toward global alignment...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Greenberg Traurig
    Greenberg Traurig
  • Article

    Beijing IP Court Issues "Reference For Case Filing In Civil Cases Involving Patent Disputes Related To Drugs Of Which Applications For Registration Are Filed (Trial Implementation)" And The Interpretation Of The Same

    The fourth revision of the "Patent Law of the People's Republic of China" has come into effect on June 1, 2021, which stipulates that "In the process of the marketing review and approval of new drugs...
    ChinaIntellectual Property
    Kangxin
    Kangxin
  • Article

    CNIPA Decides First Batch Of Administrative Adjudications Of Significant Patent Infringement Disputes

    The amended Patent Law came into effect on June 1, 2021, in which the new added Article 70, paragraph 1 endows the CNIPA with the authority to solve patent infringement disputes which have a significant impact nationwide ...
    ChinaIntellectual Property
    Lung Tin
    Lung Tin
  • Article

    Counterfeit Alcohol – Coming Soon To A Glass Near You?

    Counterfeit production is a thriving industry in the People’s Republic of China (PRC); imitators profit from a wide variety of products ranging from fake consumer goods, to industrial products, to wine and spirits.
    ChinaIntellectual Property
    Carroll, Burdick & McDonough LLP
    Carroll, Burdick & McDonough LLP
  • Showing 281–300 of 483 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics